Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Transitional Cell Carcinoma
Interventions
DRUG

Gemcitabine and cisplatin

"Neoadjuvant chemotherapy (gemcitabine and cisplatin) administered before Nephroureterectomy.~Chemotherapy regimen of three cycles of gemcitabine and cisplatin, dosed over a 3 month period Each cycle would consist of gemcitabine and cisplatin on day 1, with two other doses of gemcitabine on day 8 and day 15.~Gemcitabine dosing would be 1,000 mg/m² and cisplatin would be dosed at 70 mg/m²"

OTHER

Retrospective comparison

60 retrospective historical cohort group of subjects who have undergone a radical nephroureterectomy over the past five years

Trial Locations (1)

01805

Lahey Clinic, Inc., Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lahey Clinic

OTHER